Megumi Oshima

2.3k total citations · 1 hit paper
49 papers, 961 citations indexed

About

Megumi Oshima is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Megumi Oshima has authored 49 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 18 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Megumi Oshima's work include Diabetes Treatment and Management (17 papers), Chronic Kidney Disease and Diabetes (12 papers) and Dialysis and Renal Disease Management (8 papers). Megumi Oshima is often cited by papers focused on Diabetes Treatment and Management (17 papers), Chronic Kidney Disease and Diabetes (12 papers) and Dialysis and Renal Disease Management (8 papers). Megumi Oshima collaborates with scholars based in Japan, Australia and United Kingdom. Megumi Oshima's co-authors include Takashi Wada, Tadashi Toyama, Miho Shimizu, Akinori Hara, Kengo Furuichi, Vlado Perkovic, Masayuki Yamanouchi, Hiddo J.L. Heerspink, Meg Jardine and Adeera Levin and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Megumi Oshima

44 papers receiving 953 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trajectories of kidney function in diabetes: a clinicopathological update

2021 206 citations Megumi Oshima, Miho Shimizu et al. Nature Reviews Nephrology profile →

Peers

Countries citing papers authored by Megumi Oshima

Since Specialization

Citations

This map shows the geographic impact of Megumi Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Oshima more than expected).

Fields of papers citing papers by Megumi Oshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Oshima. The network helps show where Megumi Oshima may publish in the future.

Co-authorship network of co-authors of Megumi Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Oshima. A scholar is included among the top collaborators of Megumi Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Oshima. Megumi Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between kidney function and healthy life expectancy: A historical cohort study 2025 ·BMC Nephrology ·Hisayuki Ogura, Tadashi Toyama, (unknown), (unknown), (unknown), Shiori Nakagawa, Megumi Oshima, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Tomoyuki Takura, Takashi Wada, Yasunori Iwata	1
2	Review no. 1: designing clinical kidney research using real-world data: research questions, data sources, and analytical skills 2025 ·Clinical and Experimental Nephrology ·Yuka Sugawara, (unknown), Hajime Nagasu, Yoshihisa Miyamoto, Megumi Oshima, Takashige Kuwabara, Tadashi Sofue, Naoki Nakagawa	0
3	Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees 2024 ·Clinical and Experimental Nephrology ·(unknown), Tadashi Toyama, Yusuke Nakade, Hisayuki Ogura, Megumi Oshima, Shiori Nakagawa, (unknown), Shinji Kitajima, Norihiko Sakai, Miho Shimizu, Yasunori Iwata, Takashi Wada	2
4	Protective Role of MAVS Signaling for Murine Lipopolysaccharide-Induced Acute Kidney Injury 2024 ·ImmunoHorizons ·(unknown), Yasunori Iwata, (unknown), Shinji Kitajima, Shiori Nakagawa, Megumi Oshima, Norihiko Sakai, Tadashi Toyama, Yuta Yamamura, (unknown), Akinori Hara, Miho Shimizu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takashi Wada	1
5	The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trial 2024 ·The Lancet Planetary Health ·(unknown), Robert A. Fletcher, Bruce Neal, Megumi Oshima, Fiona Adshead, Keith M. Moore, Forbes McGain, Scott McAlister, Katherine A. Barraclough, John Knight, Brendon L. Neuen, Clare Arnott	5
6	A comprehensive risk factor analysis using association rules in people with diabetic kidney disease 2023 ·Scientific Reports ·Tadashi Toyama, Miho Shimizu, Taihei Yamaguchi, (unknown), (unknown), Megumi Oshima, Shinji Kitajima, Akinori Hara, Norihiko Sakai, (unknown), (unknown), Atsushi Tajima, Kengo Furuichi, Takashi Wada, Yasunori Iwata	0
7	Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease 2023 ·Kidney International Reports ·Masayuki Yamanouchi, Naoki Sawa, Tadashi Toyama, Miho Shimizu, Megumi Oshima, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Yuki Oba, (unknown), Hiroki Mizuno, Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Yoshifumi Ubara, Shigeko Hara, Kengo Furuichi, Takashi Wada	4
8	Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study 2023 ·Clinical Therapeutics ·Megumi Oshima, Tadashi Toyama, Yusuke Nakade, (unknown), (unknown), (unknown), (unknown), Hisayuki Ogura, Shiori Nakagawa, Taro Miyagawa, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Masashi Mita, Masashi Kinoshita, Mitsutoshi Nakada, Mitsuru Kikuchi, Yasunori Iwata, Takashi Wada	3
9	Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study 2022 ·Biomedicines ·Yasuhiro Mochida, Akinori Hara, Machiko Oka, Kyoko Maesato, Kunihiro Ishioka, Hidekazu Moriya, Megumi Oshima, Tadashi Toyama, Shinji Kitajima, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Yoshitaka Koshino, Takayasu Ohtake, Sumi Hidaka, Shuzo Kobayashi, Takashi Wada	2
10	Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes 2022 ·Journal of Human Hypertension ·Katie Harris, Paul Muntner, Mark Woodward, Min Jun, Megumi Oshima, Jessica Gong, Stephen Harrap, Joël Ménard, John Chalmers	2
11	Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury 2021 ·Biology Open ·Taro Miyagawa, Yasunori Iwata, Megumi Oshima, Hisayuki Ogura, Kōichi Sato, Shiori Nakagawa, Yuta Yamamura, (unknown), (unknown), Shinji Kitajima, Tadashi Toyama, Akinori Hara, Norihiko Sakai, Miho Shimizu, Kengo Furuichi, Seiichi Munesue, Yasuhiko Yamamoto, Shuichi Kaneko, Takashi Wada	15
12	Trajectories of kidney function in diabetes: a clinicopathological update breakdown → 2021 ·Nature Reviews Nephrology ·Megumi Oshima, Miho Shimizu, Masayuki Yamanouchi, Tadashi Toyama, Akinori Hara, Kengo Furuichi, Takashi Wada	206
13	Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell 2021 ·BMC Nephrology ·Yasunori Iwata, Norihiko Sakai, Yuki Nakajima, Megumi Oshima, Shiori Nakagawa, Hisayuki Ogura, Kōichi Sato, (unknown), Shinji Kitajima, Tadashi Toyama, Yuta Yamamura, Taro Miyagawa, Akinori Hara, Miho Shimizu, Kengo Furuichi, Takashi Wada	2
14	Relationships between kidney dysfunction and left ventricular diastolic dysfunction: a hospital-based retrospective study 2021 ·Journal of Nephrology ·(unknown), Tadashi Toyama, Mika Mori, Yusuke Nakade, Kōichi Sato, Yuta Yamamura, Hisayuki Ogura, Shiori Nakagawa, Megumi Oshima, Taro Miyagawa, Soichiro Usui, (unknown), Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Yoshio Sakai, Kengo Furuichi, Takashi Wada	4
15	Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice 2020 ·Kidney International ·Megumi Oshima, Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Adeera Levin, Soo Kun Lim, Kenneth W. Mahaffey, Bruce Neal, Carol A. Pollock, Norman Rosenthal, David C. Wheeler, Hong Zhang, Bernard Zinman, Vlado Perkovic, Hiddo J.L. Heerspink	114
16	Polyarteritis nodosa with perirenal hematoma due to the rupture of a renal artery aneurysm 2020 ·CEN Case Reports ·Taro Miyagawa, Yasunori Iwata, Megumi Oshima, Hisayuki Ogura, Kōichi Sato, Shiori Nakagawa, Yuta Yamamura, Shinji Kitajima, Tadashi Toyama, Akinori Hara, Satoshi Kokubo, Norihiko Sakai, Miho Shimizu, Kengo Furuichi, Takashi Wada	3
17	Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor 2020 ·Kidney International Reports ·Megumi Oshima, Akinori Hara, Tadashi Toyama, Min Jun, Carol A. Pollock, Meg Jardine, Stephen Harrap, Neil R Poulter, Mark E. Cooper, Mark Woodward, John Chalmers, Vlado Perkovic, Muh Geot Wong, Takashi Wada	7
18	Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study 2020 ·Diabetologia ·Katie Harris, Megumi Oshima, Naveed Sattar, Peter Würtz, Min Jun, Paul Welsh, Pavel Hamet, Stephen Harrap, Neil R Poulter, John Chalmers, Mark Woodward	26
19	Association between the recurrence period of acute kidney injury and mortality: a single-centre retrospective observational study in Japan 2019 ·BMJ Open ·(unknown), Kengo Furuichi, Yuta Yamamura, Megumi Oshima, Tadashi Toyama, Shuichi Kaneko, Takashi Wada	8
20	Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes 2018 ·PLoS ONE ·Megumi Oshima, Tadashi Toyama, Masakazu Haneda, Kengo Furuichi, Tetsuya Babazono, Hiroki Yokoyama, Kunitoshi Iseki, Shin‐ichi Araki, Toshiharu Ninomiya, Shigeko Hara, Yoshiki Suzuki, Masayuki Iwano, Eiji Kusano, Tatsumi Moriya, Hiroaki Satoh, Hiroyuki Nakamura, Miho Shimizu, Akinori Hara, Hirofumi Makino, Takashi Wada	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact